Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
- In Phase 1, to evaluate the dose response of aliskiren in msSBP change at end of Phase 1 from the baseline, as measured by office blood pressure reading, in children 6 to 17 years old with hypertension. - In Phase 2 (placebo controlled phase), to evaluate pooled treatment effect of aliskiren in msSBP change at end of Phase 2 from the end of Phase 1, compared to placebo pooled from corresponding arms, as measured by office blood pressure reading, in children 6 to 17 years old with hypertension.
Inclusion criteria
- Hypertension